PlainRecalls
FDA Drug Moderate Class II Terminated

PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

Reported: April 17, 2019 Initiated: February 21, 2019 #D-1091-2019

Product Description

PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

Reason for Recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Details

Units Affected
5 prescriptions 5,10, 6, 9 ml injectable
Distribution
Dispensed in Oregon
Location
Corvallis, OR

Frequently Asked Questions

What product was recalled?
PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .. Recalled by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy. Units affected: 5 prescriptions 5,10, 6, 9 ml injectable.
Why was this product recalled?
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 17, 2019. Severity: Moderate. Recall number: D-1091-2019.